Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Feng

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Molecular Biology Reports|February 25, 2016
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patientsAshraf Bakkar, Mohammed Alshalalfa, Lars F Petersen, et al.
NPJ Digital Medicine|October 8, 2021
Biological data annotation via a human-augmenting AI-based labeling systemDouwe van der Wal, Iny Jhun, Israa Laklouk, et al.
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Cell Chemical Biology|February 2, 2022
Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancerArielle Shkedi, Isabelle R Taylor, Frank Echtenkamp, et al.
European Urology Oncology|August 9, 2023
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate CancerPhilip Sutera, Amol C Shetty, Yang Song, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
European Urology Open Science|December 10, 2020
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular SubtypesSalma Ben-Salem, Qiang Hu, Yang Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET ImagingHossein Jadvar, Jeremie Calais, Stefano Fanti, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate CancerLisanne Mout, Thaidy Moreno-Rodriguez, Giacomo Grillo, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Molecular Biology Reports|February 25, 2016
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patientsAshraf Bakkar, Mohammed Alshalalfa, Lars F Petersen, et al.
NPJ Digital Medicine|October 8, 2021
Biological data annotation via a human-augmenting AI-based labeling systemDouwe van der Wal, Iny Jhun, Israa Laklouk, et al.
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Cell Chemical Biology|February 2, 2022
Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancerArielle Shkedi, Isabelle R Taylor, Frank Echtenkamp, et al.
European Urology Oncology|August 9, 2023
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate CancerPhilip Sutera, Amol C Shetty, Yang Song, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
European Urology Open Science|December 10, 2020
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular SubtypesSalma Ben-Salem, Qiang Hu, Yang Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET ImagingHossein Jadvar, Jeremie Calais, Stefano Fanti, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate CancerLisanne Mout, Thaidy Moreno-Rodriguez, Giacomo Grillo, et al.
Pageof 8